156 related articles for article (PubMed ID: 37629101)
1. Comparative Thrombin Generation in Animal Plasma: Sensitivity to Human Factor XIa and Tissue Factor.
Liang Y; Tarandovskiy I; Surov SS; Ovanesov MV
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629101
[TBL] [Abstract][Full Text] [Related]
2. The effect of factor XIa on thrombin and plasmin generation, clot formation, lysis and density in coagulation factors deficiencies.
Tarandovskiy ID; Ovanesov MV
Thromb Res; 2024 Jan; 233():189-199. PubMed ID: 38101192
[TBL] [Abstract][Full Text] [Related]
3. Thrombogenic potential of picomolar coagulation factor XIa is mediated by thrombin wave propagation.
Parunov LA; Liang Y; Lu Q; Shibeko AM; Tucker EI; Lee TK; Ataullakhanov FI; Scott DE; Ovanesov MV
Blood Adv; 2023 Jun; 7(11):2622-2631. PubMed ID: 36724509
[TBL] [Abstract][Full Text] [Related]
4. Reduced model to predict thrombin and fibrin during thrombosis on collagen/tissue factor under venous flow: Roles of γ'-fibrin and factor XIa.
Chen J; Diamond SL
PLoS Comput Biol; 2019 Aug; 15(8):e1007266. PubMed ID: 31381558
[TBL] [Abstract][Full Text] [Related]
5. FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow.
Zhu S; Travers RJ; Morrissey JH; Diamond SL
Blood; 2015 Sep; 126(12):1494-502. PubMed ID: 26136249
[TBL] [Abstract][Full Text] [Related]
6. Effect of factor XI inhibition on tumor cell-induced coagulation activation.
Mäder J; Rolling CC; Voigtländer M; Schulenkorf A; Lehr C; Regenhardt J; Bokemeyer C; Beckmann L; Langer F
J Thromb Haemost; 2024 Jan; 22(1):199-212. PubMed ID: 37751848
[TBL] [Abstract][Full Text] [Related]
7. Thrombin generation assay using factor XIa to measure factors VIII and IX and their glycoPEGylated derivatives is robust and sensitive.
Waters EK; Hilden I; Sørensen BB; Ezban M; Holm PK
J Thromb Haemost; 2015 Nov; 13(11):2041-52. PubMed ID: 26340413
[TBL] [Abstract][Full Text] [Related]
8. Synergy Between Tissue Factor and Exogenous Factor XIa in Initiating Coagulation.
Leiderman K; Chang WC; Ovanesov M; Fogelson AL
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2334-2345. PubMed ID: 27789475
[TBL] [Abstract][Full Text] [Related]
9. Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease.
Paszek E; Malinowski KP; Ząbczyk M; Butenas S; Undas A
Eur J Clin Invest; 2023 Sep; 53(9):e14007. PubMed ID: 37042848
[TBL] [Abstract][Full Text] [Related]
10. Activated factor XI and tissue factor in chronic obstructive pulmonary disease: links with inflammation and thrombin generation.
Jankowski M; Undas A; Kaczmarek P; Butenas S
Thromb Res; 2011 Mar; 127(3):242-6. PubMed ID: 21236471
[TBL] [Abstract][Full Text] [Related]
11. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
Wong PC; Jiang X
Thromb Haemost; 2010 Aug; 104(2):302-10. PubMed ID: 20589316
[TBL] [Abstract][Full Text] [Related]
12. Optimization of the thrombin generation test components to measure potency of factor VIII concentrates.
Jha NK; Shestopal SA; Gourley MJ; Woodle SA; Liang Y; Sarafanov AG; Weinstein M; Ovanesov MV
Haemophilia; 2016 Sep; 22(5):780-9. PubMed ID: 27038076
[TBL] [Abstract][Full Text] [Related]
13. Interconnectedness of global hemostasis assay parameters in simultaneously evaluated thrombin generation, fibrin generation and clot lysis in normal plasma.
Xin KZ; Chang WC; Ovanesov MV
Thromb Res; 2016 Apr; 140():132-139. PubMed ID: 26632515
[TBL] [Abstract][Full Text] [Related]
14. A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X.
Ogiwara K; Nogami K; Matsumoto N; Noguchi-Sasaki M; Hirata M; Soeda T; Shima M
Int J Hematol; 2020 Nov; 112(5):621-630. PubMed ID: 32748217
[TBL] [Abstract][Full Text] [Related]
15. Sensitive Measurement of Clinically Relevant Factor VIII Levels in Thrombin Generation Assays Requires Presence of Factor XIa.
van de Berg TW; Beckers EAM; Heubel-Moenen FCJI; Henskens YMC; Thomassen MCLGD; Hackeng TM
Thromb Haemost; 2023 Nov; 123(11):1034-1041. PubMed ID: 37236229
[TBL] [Abstract][Full Text] [Related]
16. Investigation of thrombin concentration at the time of clot formation in simultaneous thrombin and fibrin generation assays.
Tarandovskiy ID; Surov SS; Parunov LA; Liang Y; Jankowski W; Sauna ZE; Ovanesov MV
Sci Rep; 2024 Apr; 14(1):9225. PubMed ID: 38649717
[TBL] [Abstract][Full Text] [Related]
17. Activated factor XI and tissue factor in aortic stenosis: links with thrombin generation.
Luszczak J; Undas A; Gissel M; Olszowska M; Butenas S
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):473-9. PubMed ID: 21519234
[TBL] [Abstract][Full Text] [Related]
18. Analysis of factor XIa, factor IXa and tissue factor activity in burn patients.
Shupp JW; Prior SM; Jo DY; Moffatt LT; Mann KG; Butenas S
Burns; 2018 Mar; 44(2):436-444. PubMed ID: 29032977
[TBL] [Abstract][Full Text] [Related]
19. Activation of blood coagulation and thrombin generation in acute ischemic stroke treated with rtPA.
Goldman S; Prior SM; Bembenek JP; Niewada M; Broniatowska E; Członkowska A; Butenas S; Undas A
J Thromb Thrombolysis; 2017 Oct; 44(3):362-370. PubMed ID: 28879581
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with the presence of circulating active tissue factor and activated factor XI in stable angina patients.
Ząbczyk M; Butenas S; Plicner D; Fijorek K; Sadowski J; Undas A
Blood Coagul Fibrinolysis; 2012 Apr; 23(3):189-94. PubMed ID: 22343680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
